VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

58 hedge funds and large institutions have $52.8M invested in Viracta Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 8 closing their positions.

Holders
58
Holders Change
-4
Holders Change %
-6.45%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
16
Reduced
16
Closed
8
Calls
$627K
Puts
$235K
Net Calls
+$392K
Net Calls Change
-$98K